 |
|
|
eFilm Workstation Hits
Record 20,000 Downloads; New Release Accelerates Healthcare
Enterprise-Wide Usage. Thousands of clinicians worldwide
utilize diagnostic imaging software for softcopy reading.
Customer feedback determines new features in release
1.8.
Milwaukee, WI, August 13, 2002
Milwaukee, WI, August 13, 2002 - Merge Technologies
Incorporated, through its recent acquisition of eFilm
Medical, attained the goal of becoming a global leader
in diagnostic imaging software tools by achieving a
record 20,000 downloads of its eFilm Workstation software.
eFilm Workstation displays diagnostic images, using
a standard PC and monitor, and provides exceptional
navigation and viewing tools for optimal radiological
interpretation. A 30-day evaluation copy of eFilm Workstation
version 1.8 is available for download at http://www.efilm.ca/products/efilmworkstation/info.htm.
"We are exceedingly proud of this accomplishment.
What started as an academic exercise in 1999 to find
a better and more cost-effective way of displaying and
manipulating images has now become an internationally
accepted methodology in radiology workflow," said
Greg Couch, Merge's Chief Technology Officer. "What
we didn't anticipate was the depth of enthusiasm of
our users. Their zealousness about eFilm Workstation
was the catalyst for continued enhancement of the product
and the addition of features, such as 3D/MIP and MPR,
in our new 1.8 release. Appreciation for our customers'
loyalty was instrumental in our decision to maintain
eFilm Workstation's high-value-for-price model. We are
committed to this unique model going forward."
"The functional efficacy and cost-effectiveness
of eFilm Workstation has allowed us to change the way
we practice Radiology," said Stanley Smazal, MD,
Radiologist at Radiology Imaging Associates of Colorado.
"We can share images with multiple clinicians,
access images from multiple locations, and view and
manipulate the images to optimize interpretation. Incorporating
eFilm Workstation into our radiology workflow has had
a significant economic and clinical impact."
"The additional functionality of version 1.8 provides
an opportunity for superior softcopy reading for hospitals,
imaging centers, and physician practices that wish to
extend the accessibility of their current PACS. It immediately
increases the number and type of clinicians who can
gain from using eFilm's powerful image viewing tools.
eFilm Workstation is also a great solution for those
who do not have the financial resources for a full PACS,"
said Matt Anderson, Chief Information Officer at University
Health Network, Toronto, Ontario, a long-time customer
of eFilm. "We have been extremely pleased with
the product and the range of support services that eFilm
offers."
Rich Linden, Merge's President and CEO said, "The
global acceptance of eFilm Workstation is indicative
of the depth of clinical and technical understanding
of radiology workflow that we possess. I'm particularly
pleased with the accelerating usage of eFilm Workstation
as an enterprise-wide method for clinical image interpretation
and review. We are well positioned to continue delivering
increased value and solution to these customers using
the combined strengths of the new Merge organization."
|
Attn: Beth Frost-Johnson
Merge Healthcare
6737 West Washington St.
Suite 2250
Milwaukee, WI 53214
|
|
|
|
|
|
| Except for the historical information herein, the matters discussed in this news release include forward-looking statements that may involve a number of risks and uncertainties. When used in this press release, the words “will,” “believes,” “intends,” “anticipates,” “expects” and similar expressions are intended to identify forward-looking statements. Actual results could differ materially from those expressed in, or implied by, the forward-looking statements based on a number of factors, including, but not limited to, the uncertainty created by, the adverse impact on relationships with customers, potential customers, suppliers and investors potentially resulting from, and other risks associated with, the changes in the Company’s senior management; costs, risks and effects of the investigation by the Audit Committee of the Board of Directors; the impact of the restatement of financial statements of the Company and other actions that may be taken or required as a result of such restatement; the Company's inability to timely file reports with the Securities and Exchange Commission; risks associated with the Company's inability to meet the requirements of The NASDAQ Stock Market for continued listing, including possible delisting; costs, risks and effects of legal proceedings and investigations, including the informal, non-public inquiry being conducted by the Securities and Exchange Commission and class action, derivative, and other lawsuits; risks in product and technology development, market acceptance of new products and continuing product demand, the impact of competitive products and pricing, ability to integrate acquisitions, changing economic conditions, credit and payment risks associated with end-user sales, dependence on major customers, dependence on key personnel, and other risk factors detailed in the Company’s filings with the Securities and Exchange Commission. Except as expressly required by the federal securities laws, the Company undertakes no obligation to update such factors or to publicly announce the results of any of the forward-looking statements contained herein to reflect future events, developments, or changed circumstances, or for any other reason.
|
|
|
